COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1335: Articles 13341-13350  | Next

SARS-CoV-2 Breakthrough Infections among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in the South Indian State of Kerala.
Issac, A., Kochuparambil, J. J., Elizabeth, L.
10.1101/2021.08.07.21261587 — Posted: 2021-08-08
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
Natarajan, H., Xu, S., Crowley, A. R., Butler, S. E., Weiner, J. A., Bloch, E. M., Littlefield, K., Benner, S. E., Shrestha, R., Ajayi, O., Weiland-Alter, W. F., Sullivan, D. J., Shoham, S., Quinn, T., Casadevall, A., Pekosz, A., Redd, A., Tobian, A. A., Connor, R. I., Wright, P. F., Ackerman, M. E.
10.1101/2021.08.06.21261710 — Posted: 2021-08-08
'I can't cope with multiple inputs': Qualitative study of the lived experiences of 'brain fog' after Covid-19
Callan, C., Ladds, E., Hussain, L., Pattinson, K., Greenhalgh, T.
10.1101/2021.08.07.21261740 — Posted: 2021-08-08 Discussion: Onsite
Machine learning detects SARS-CoV-2 and variants rapidly on DNA aptamer metasurfaces
Torun, H., Bilgin, B., Ilgu, M., Yanik, C., Batur, S. N., Celik, S., Ozturk, M., Dogan, O., Ergonul, O., Solaroglu, I., Can, F., Onbasli, M. C.
10.1101/2021.08.07.21261749 — Posted: 2021-08-08
A Machine Learning Model Incorporating Laboratory Blood Tests Discriminates Between SARS-CoV-2 and Influenza Infections at Emergency Department Visit
Liu, J., Westblade, L. F., Chadburn, A., Fideli, R., Craney, A., Rand, S., Cushing, M., zhao, Z., Meng, J., Yang, H. S.
10.1101/2021.08.06.21261713 — Posted: 2021-08-08
Deconvoluting complex correlates of COVID19 severity with local ancestry inference and viral phylodynamics: Results of a multiomic pandemic tracking strategy
Parikh, V. N., Ioannidis, A. G., Jimenez-Morales, D., Gorzynski, J. E., De Jong, H. N., Liu, X., Roque, J., Cepeda-Espinoza, V. P., Osoegawa, K., Hughes, C., Sutton, S. C., Youlton, N., Joshi, R., Amar, D., Tanigawa, Y., Russo, D., Wong, J., Lauzon, J. T., Edelson, J., Montserrat, D. M., Kwon, Y., Rubinacci, S., Delaneau, O., Cappello, L., Kim, J., Shoura, M. J., Raja, A. N., Watson, N., Hammond, N., Spiteri, E., Mallempati, K. C., Montero-Martin, G., Christle, J., Kim, J., Kirillova, A., Seo, K., Huang, Y., Zhao, C., Moreno-Grau, S., Hershman, S., Dalton, K. P., Zhen, J., Kamm, J., Bhatt, K., Isakova, A., Morri, M., Ranganath, T., Blish, C. A., Rogers, A. J., Nadeau, K., Yang, S., Blomkalns, A., OHara, R., Neff, N. F., DeBoever, C., Szalma, S., Wheeler, M. T., Farh, K., Schroth, G. P., Febbo, P., deSouza, F., Fernandez-Vina, M., Kistler, A., Palacios, J., Pinsky, B. A., Bustamante, C. D., Rivas, M. A., Ashley, E. A.
10.1101/2021.08.04.21261547 — Posted: 2021-08-08
High genetic barrier to escape from human polyclonal SARS-CoV-2 neutralizing antibodies
Schmidt, F., Weisblum, Y., Rutkowska, M., Poston, D., Da Silva, J., Zhang, F., Bednarski, E., Cho, A., Schaefer-Babajew, D., Gaebler, C., Caskey, M., Nussenzweig, M. C., Hatziioannou, T., Bieniasz, P. D.
10.1101/2021.08.06.455491 — Posted: 2021-08-08
Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)
Lo, M. K., Shrivastava-Ranjan, P., Chatterjee, P., Flint, M., Beadle, J. R., Valiaeva, N., Schooley, R., Hostetler, K. Y., Montgomery, J., Spiropoulou, C. F.
10.1101/2021.08.06.455494 — Posted: 2021-08-08
The emergence of highly fit SARS-CoV-2 variants accelerated by recombination
Garvin, M. R., Prates, E. T., Romero, J., Cliff, A., Gazolla, J. G. F. M., Pickholz, M., Pavicic, M., Jacobson, D.
10.1101/2021.08.03.454981 — Posted: 2021-08-08
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers
Abe, K. T., Hu, Q., Mozafarihashjin, M., Samson, R., Manguiat, K., Robinson, A., Rathod, B., Chao, G., Wang, J. H., Iskilova, M., Pasculescu, A., Fazel-Zarandi, M., Li, A., Paterson, A., Green, K., Gilbert, L., Barati, S., Haq, N., Takaoka, A., Garnham Takaoka, J., Quinn De Launay, K., Fahim, C., Sheikh-Mohamed, S., Arita, Y., Durocher, Y., Marcusson, E. G., Gommerman, J. L., Ostrowski, M., Colwill, K., Straus, S. E., Wood, H., McGeer, A. J., Gingras, A.-C.
10.1101/2021.08.06.21261721 — Posted: 2021-08-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).